Tinavi Medical Technologies Co., Ltd.

Tinavi Medical Technologies Co., Ltd. has shown strong stock performance, with a 5.22% increase on June 17, 2026, and a 19.01% gain over the past week. Over the last year, the company has achieved a 48.26% rise, contrasting with broader market trends, despite facing operational challenges.

Tinavi Medical Technologies Co., Ltd. saw a notable stock decline, contrasting with the broader market's modest decrease. Despite a year-to-date increase, the company has struggled over the past three years. Financial metrics indicate challenges, including low profitability and negative net worth, within the pharmaceuticals and biotechnology sector.

Tinavi Medical Technologies Co., Ltd. experienced notable stock activity, outperforming the China Shanghai Composite in the short term. However, its longer-term performance reveals challenges, including a significant decline over five years and a low return on capital employed, alongside pressures on its operating profit margin.

Tinavi Medical Technologies Co., Ltd. experienced notable stock volatility, hitting an intraday low and reflecting a decline for the day. Despite recent challenges, including negative financial metrics, the company has shown strong annual growth and significant year-to-date gains, outperforming the broader market index.

Tinavi Medical Technologies Co., Ltd. has seen a notable rise in its stock performance, achieving significant gains over various time frames, including an impressive annual return. Despite these short-term successes, the company faces challenges such as low return on capital and negative net worth, which may affect its long-term growth.

Tinavi Medical Technologies Co., Ltd. saw a significant stock decline today, contrasting with broader market trends. Despite a strong yearly performance, the company faces operational challenges, including a negative operating profit margin and low return on capital. Its market capitalization is CNY 8,502 million, with limited long-term growth prospects.